J A Schmidt1, A Gorst-Rasmussen2, P W Nyström3, J H Christensen4, E B Schmidt2, C Dethlefsen2, A Tjønneland5, K Overvad6, C C Dahm7. 1. 1] Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK [2] Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark. 2. Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark. 3. Department of Oncology, University Hospital of Uppsala, Uppsala, Sweden. 4. Department of Nephrology, Aalborg University Hospital, Aalborg, Denmark. 5. Diet, Genes and Environment Unit, Danish Cancer Society Research Center, Copenhagen, Denmark. 6. 1] Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark [2] Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark. 7. Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.
Abstract
BACKGROUND/ OBJECTIVES: The evidence regarding fatty acids and breast cancer risk is inconclusive. Adipose tissue fatty acids can be used as biomarkers of fatty acid intake and of endogenous fatty acid exposure. Fatty acids in adipose tissue are correlated owing to common dietary sources and shared metabolic pathways, which group fatty acids into naturally occurring patterns. We aimed to prospectively investigate associations between adipose tissue fatty acid patterns and long-term risk of total breast cancer and breast cancer subtypes characterised by oestrogen and progesterone receptor status (ER and PR). SUBJECTS/ METHODS: This case-cohort study was based on data from the Danish cohort Diet, Cancer and Health. At baseline, a fat biopsy and information on lifestyle and reproductive factors were collected. From the 31 original fatty acids measured, patterns of fatty acids were identified using the treelet transform. During a median follow-up of 5.3 years, 474 breast cancer cases were identified. Hazard ratios and 95% confidence intervals of risk of total breast cancer and of subtypes according to quintiles of factor score were determined by weighted Cox proportional hazards regression. RESULTS: After adjustment for potential confounders, factor scores for the seven patterns identified by the treelet transform were not associated with risk of total breast cancer, nor with risk of ER+, ER-, PR+ or PR- tumours. CONCLUSIONS: No clear associations between the patterns of fatty acids at baseline and long-term risk of total breast cancer or ER+, ER-, PR+ or PR- tumours were observed.
BACKGROUND/ OBJECTIVES: The evidence regarding fatty acids and breast cancer risk is inconclusive. Adipose tissue fatty acids can be used as biomarkers of fatty acid intake and of endogenous fatty acid exposure. Fatty acids in adipose tissue are correlated owing to common dietary sources and shared metabolic pathways, which group fatty acids into naturally occurring patterns. We aimed to prospectively investigate associations between adipose tissue fatty acid patterns and long-term risk of total breast cancer and breast cancer subtypes characterised by oestrogen and progesterone receptor status (ER and PR). SUBJECTS/ METHODS: This case-cohort study was based on data from the Danish cohort Diet, Cancer and Health. At baseline, a fat biopsy and information on lifestyle and reproductive factors were collected. From the 31 original fatty acids measured, patterns of fatty acids were identified using the treelet transform. During a median follow-up of 5.3 years, 474 breast cancer cases were identified. Hazard ratios and 95% confidence intervals of risk of total breast cancer and of subtypes according to quintiles of factor score were determined by weighted Cox proportional hazards regression. RESULTS: After adjustment for potential confounders, factor scores for the seven patterns identified by the treelet transform were not associated with risk of total breast cancer, nor with risk of ER+, ER-, PR+ or PR- tumours. CONCLUSIONS: No clear associations between the patterns of fatty acids at baseline and long-term risk of total breast cancer or ER+, ER-, PR+ or PR- tumours were observed.
Authors: S J London; F M Sacks; M J Stampfer; I C Henderson; M Maclure; A Tomita; W C Wood; S Remine; N J Robert; J R Dmochowski Journal: J Natl Cancer Inst Date: 1993-05-19 Impact factor: 13.506
Authors: G Mamalakis; C Hatzis; E de Bree; E Sanidas; D D Tsiftsis; J Askoxylakis; M Daskalakis; G Tsibinos; A Kafatos Journal: Ann Nutr Metab Date: 2009-07-27 Impact factor: 3.374
Authors: Anne Tjønneland; Anja Olsen; Katja Boll; Connie Stripp; Jane Christensen; Gerda Engholm; Kim Overvad Journal: Scand J Public Health Date: 2007 Impact factor: 3.021
Authors: Jackilen Shannon; Irena B King; Rachel Moshofsky; Johanna W Lampe; Dao Li Gao; Roberta M Ray; David B Thomas Journal: Am J Clin Nutr Date: 2007-04 Impact factor: 7.045
Authors: Pia Thisted Dinesen; Thomas Andersen Rix; Albert Marni Joensen; Christina Cathrine Dahm; Søren Lundbye-Christensen; Erik Berg Schmidt; Kim Overvad Journal: PLoS One Date: 2018-12-11 Impact factor: 3.240
Authors: Marnie Newell; Sunita Ghosh; Susan Goruk; Mohammedreza Pakseresht; Jennifer E Vena; Trevor J B Dummer; Catherine J Field Journal: Curr Dev Nutr Date: 2021-03-25